The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 02, 2022
Filed:
Sep. 12, 2018
Applicant:
Glaxosmithkline Intellectual Property Development Limited, Brentford, GB;
Inventors:
Sanjay Khandekar, Collegeville, PA (US);
Patrick Mayes, Devon, PA (US);
Joanna Opalinska, Collegeville, PA (US);
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, Brentford, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 31/573 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 19/00 (2006.01); A61K 47/68 (2017.01); A61P 35/00 (2006.01); A61K 31/69 (2006.01); C07K 14/71 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2878 (2013.01); A61K 31/573 (2013.01); A61K 31/69 (2013.01); A61K 39/3955 (2013.01); A61K 39/39558 (2013.01); A61K 47/6817 (2017.08); A61P 35/00 (2018.01); C07K 16/2896 (2013.01); C07K 16/30 (2013.01); C07K 19/00 (2013.01); A61K 2039/505 (2013.01); A61K 2039/545 (2013.01); C07K 2317/56 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01); C07K 2319/55 (2013.01);
Abstract
Disclosed herein is a method of treating cancer, such as multiple myeloma, involving the combination of an anti-BCMA antigen binding protein (e.g., an anti-BCMA antibody) and a proteasome inhibitor (e.g. bortezomib). The combinations can also include an anti-inflammatory compound (e.g. dexamethasone).